|
Market Cap (4-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 6 December 2022, 8:59. The announcement is marked as price sensitive, and is 2 page(s) in length and 279.08kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.602% short sold according to ASIC data. It was ranked the 288th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| GMP Manufacturing Process Developed for IMP761 LAG-3 Agonist | 6 December 2022, 8:59 |
| Immutep enters 2nd collaboration with Pfizer and Merck KGaA | 29 November 2022, 8:14 |
| Results of Meeting | 23 November 2022, 13:01 |
| Immutep AGM 2022 - CEO's Presentation | 23 November 2022, 8:18 |
You must be logged in to post a reply.
